These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 15318937)

  • 1. Enrichment methods to detect bone marrow micrometastases in breast carcinoma patients: clinical relevance.
    Choesmel V; Pierga JY; Nos C; Vincent-Salomon A; Sigal-Zafrani B; Thiery JP; Blin N
    Breast Cancer Res; 2004; 6(5):R556-70. PubMed ID: 15318937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A relevant immunomagnetic assay to detect and characterize epithelial cell adhesion molecule-positive cells in bone marrow from patients with breast carcinoma: immunomagnetic purification of micrometastases.
    Choesmel V; Anract P; Høifødt H; Thiery JP; Blin N
    Cancer; 2004 Aug; 101(4):693-703. PubMed ID: 15305398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rare expression of epithelial cell adhesion molecule on residual micrometastatic breast cancer cells after adjuvant chemotherapy.
    Thurm H; Ebel S; Kentenich C; Hemsen A; Riethdorf S; Coith C; Wallwiener D; Braun S; Oberhoff C; Jänicke F; Pantel K
    Clin Cancer Res; 2003 Jul; 9(7):2598-604. PubMed ID: 12855636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow micrometastases in advanced stage non-small cell lung carcinoma patients.
    Brunsvig PF; Flatmark K; Aamdal S; Høifødt H; Le H; Jakobsen E; Sandstad B; Fodstad O
    Lung Cancer; 2008 Aug; 61(2):170-6. PubMed ID: 18261824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bi-specific immunomagnetic enrichment of micrometastatic tumour cell clusters from bone marrow of cancer patients.
    Woelfle U; Breit E; Zafrakas K; Otte M; Schubert F; Müller V; Izbicki JR; Löning T; Pantel K
    J Immunol Methods; 2005 May; 300(1-2):136-45. PubMed ID: 15907331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal residual disease in bone marrow and peripheral blood of patients with metastatic breast cancer.
    Bischoff J; Rosenberg R; Dahm M; Janni W; Gutschow K
    Recent Results Cancer Res; 2003; 162():135-40. PubMed ID: 12790327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and molecular profiling of bone marrow micrometastases identifies TWIST1 as a marker of early tumor relapse in breast cancer patients.
    Watson MA; Ylagan LR; Trinkaus KM; Gillanders WE; Naughton MJ; Weilbaecher KN; Fleming TP; Aft RL
    Clin Cancer Res; 2007 Sep; 13(17):5001-9. PubMed ID: 17785550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody therapy with edrecolomab in breast cancer patients: monitoring of elimination of disseminated cytokeratin-positive tumor cells in bone marrow.
    Braun S; Hepp F; Kentenich CR; Janni W; Pantel K; Riethmüller G; Willgeroth F; Sommer HL
    Clin Cancer Res; 1999 Dec; 5(12):3999-4004. PubMed ID: 10632331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomagnetic enrichment of disseminated tumor cells in bone marrow and blood of breast cancer patients by the Thomsen-Friedenreich-Antigen.
    Schindlbeck C; Stellwagen J; Jeschke U; Karsten U; Rack B; Janni W; Jückstock J; Tulusan A; Sommer H; Friese K
    Clin Exp Metastasis; 2008; 25(3):233-40. PubMed ID: 18185913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased sensitivity for detection of micrometastases in bone-marrow/peripheral-blood stem-cell products from breast-cancer patients by negative immunomagnetic separation.
    Naume B; Borgen E; Nesland JM; Beiske K; Gilen E; Renolen A; Ravnås G; Qvist H; Kåresen R; Kvalheim G
    Int J Cancer; 1998 Nov; 78(5):556-60. PubMed ID: 9808522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the presence of bone marrow micrometastases with the sentinel lymph node status in 410 early stage breast cancer patients: results of the Swiss Multicenter Study.
    Langer I; Guller U; Koechli OR; Berclaz G; Singer G; Schaer G; Fehr MK; Hess T; Oertli D; Bronz L; Schnarwyler B; Wight E; Uehlinger U; Infanger E; Burger D; Zuber M;
    Ann Surg Oncol; 2007 Jun; 14(6):1896-903. PubMed ID: 17356955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ErbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients.
    Braun S; Schlimok G; Heumos I; Schaller G; Riethdorf L; Riethmüller G; Pantel K
    Cancer Res; 2001 Mar; 61(5):1890-5. PubMed ID: 11280743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative characteristic of the methods of immunocytochemistry and immunomagnetic separation for detection of cytokeratin-positive cells in bone marrow and lymph nodes].
    Lebedinskaia OV; Shubina IZh; Donenko F; Pirogov AV; Kiselevskiĭ MV
    Morfologiia; 2007; 132(4):81-6. PubMed ID: 17969436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomagnetic enrichment and detection of micrometastases in colorectal cancer: correlation with established clinical parameters.
    Weihrauch MR; Skibowski E; Koslowsky TC; Voiss W; Re D; Kuhn-Regnier F; Bannwarth C; Siedek M; Diehl V; Bohlen H
    J Clin Oncol; 2002 Nov; 20(21):4338-43. PubMed ID: 12409333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of disseminated tumor cells in the bone marrow of breast cancer patients by the Thomsen-Friedenreich tumor antigen.
    Schindlbeck C; Jeschke U; Schulze S; Karsten U; Janni W; Rack B; Sommer H; Friese K
    Histochem Cell Biol; 2005 Jun; 123(6):631-7. PubMed ID: 15889266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A summary of two clinical studies on tumor cell dissemination in primary and metastatic breast cancer: methods, prognostic significance and implication for alternative treatment protocols (Review).
    Kasimir-Bauer S; Oberhoff C; Schindler AE; Seeber S
    Int J Oncol; 2002 May; 20(5):1027-34. PubMed ID: 11956600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitive detection of micrometastases in bone marrow from patients with breast cancer using immunomagnetic isolation of tumor cells in combination with reverse transcriptase/polymerase chain reaction for cytokeratin-19.
    Zhong XY; Kaul S; Lin YS; Eichler A; Bastert G
    J Cancer Res Clin Oncol; 2000 Apr; 126(4):212-8. PubMed ID: 10782894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Her2 expression on disseminated tumor cells from bone marrow of breast cancer patients.
    Becker S; Becker-Pergola G; Fehm T; Wallwiener D; Solomayer EF
    Anticancer Res; 2005; 25(3B):2171-5. PubMed ID: 16158960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomagnetic detection of micrometastatic cells in bone marrow of uveal melanoma patients: a paradox.
    Eide N; Faye RS; Høifødt HK; Sandstad B; Qvale G; Faber R; Jebsen P; Kvalheim G; Fodstad Ø
    Acta Ophthalmol; 2015 Feb; 93(1):59-66. PubMed ID: 25613126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic characteristics of cell lines derived from disseminated cancer cells in bone marrow of patients with solid epithelial tumors: establishment of working models for human micrometastases.
    Putz E; Witter K; Offner S; Stosiek P; Zippelius A; Johnson J; Zahn R; Riethmüller G; Pantel K
    Cancer Res; 1999 Jan; 59(1):241-8. PubMed ID: 9892213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.